O	O	0	2	Ex	Ex	B-NP	FW	O	2	AMOD	O
O	O	3	7	vivo	vivo	I-NP	FW	O	3	NMOD	O
O	O	8	18	activation	activation	I-NP	NN	O	12	SUB	O
O	O	19	21	of	of	B-PP	IN	O	3	NMOD	O
O	O	22	27	tumor	tumor	B-NP	NN	B-cell_type	11	NMOD	B-cell_type
O	O	27	28	-	-	O	HYPH	I-cell_type	5	P	I-cell_type
O	O	28	36	draining	drain	B-VP	VBG	I-cell_type	11	NMOD	I-cell_type
O	O	37	42	lymph	lymph	B-NP	NN	I-cell_type	11	NMOD	I-cell_type
O	O	43	47	node	node	I-NP	NN	I-cell_type	11	NMOD	I-cell_type
O	O	48	49	T	T	I-NP	NN	I-cell_type	11	NMOD	I-cell_type
O	O	50	55	cells	cell	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	56	64	reverses	reverse	B-VP	VBZ	O	0	ROOT	O
O	O	65	72	defects	defect	B-NP	NNS	O	12	OBJ	O
O	O	73	75	in	in	B-PP	IN	O	13	NMOD	O
O	O	76	82	signal	signal	B-NP	NN	B-protein	17	NMOD	B-protein
O	O	83	95	transduction	transduction	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	96	105	molecules	molecule	I-NP	NNS	I-protein	14	PMOD	I-protein
O	O	105	106	.	.	O	.	O	12	P	O

O	O	108	111	The	The	B-NP	DT	O	3	NMOD	O
O	O	112	120	adoptive	adoptive	I-NP	JJ	O	3	NMOD	O
O	O	121	129	transfer	transfer	I-NP	NN	O	15	SUB	O
O	O	130	132	of	of	B-PP	IN	O	3	NMOD	O
O	O	133	138	tumor	tumor	B-NP	NN	B-cell_type	14	NMOD	B-cell_type
O	O	138	139	-	-	O	HYPH	I-cell_type	5	P	I-cell_type
O	O	139	147	draining	drain	B-VP	VBG	I-cell_type	14	NMOD	I-cell_type
O	O	148	153	lymph	lymph	B-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	154	158	node	node	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	159	160	(	(	O	(	I-cell_type	12	DEP	I-cell_type
O	O	160	162	LN	LN	B-NP	NN	I-cell_type	12	DEP	I-cell_type
O	O	162	163	)	)	O	)	I-cell_type	14	NMOD	I-cell_type
O	O	164	165	T	T	B-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	166	171	cells	cell	I-NP	NNS	I-cell_type	4	PMOD	I-cell_type
O	O	172	181	activated	activate	B-VP	VBD	O	0	ROOT	O
O	O	182	184	ex	ex	B-ADVP	FW	O	15	VMOD	O
O	O	185	189	vivo	vivo	I-ADVP	FW	O	16	AMOD	O
O	O	190	194	with	with	B-PP	IN	O	15	VMOD	O
O	O	195	199	anti	anti	B-NP	AFX	O	18	PMOD	O
O	O	199	200	-	-	I-NP	HYPH	O	19	NMOD	O
T16	B-Entity	200	203	CD3	CD3	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	204	207	and	and	O	CC	O	23	NMOD	O
T1	B-Protein	208	219	interleukin	interleukin	B-NP	NN	B-protein	20	OBJ	B-protein
T1	I-Protein	220	221	2	2	I-NP	CD	I-protein	23	NMOD	I-protein
O	O	222	223	(	(	O	(	O	23	NMOD	O
T2	B-Protein	223	225	IL	IL	B-NP	NN	B-protein	30	SUB	B-protein
T2	I-Protein	225	226	-	-	B-ADJP	HYPH	I-protein	28	DEP	I-protein
T2	I-Protein	226	227	2	2	B-LST	LS	I-protein	30	VMOD	I-protein
O	O	227	228	)	)	O	)	O	28	DEP	O
O	O	229	237	mediates	mediate	B-VP	VBZ	O	25	SBAR	O
O	O	238	241	the	the	B-NP	DT	O	32	NMOD	O
O	O	242	252	regression	regression	I-NP	NN	O	30	OBJ	O
O	O	253	255	of	of	B-PP	IN	O	32	NMOD	O
O	O	256	259	the	the	B-NP	DT	O	39	NMOD	O
O	O	260	266	poorly	poorly	I-NP	RB	O	36	AMOD	O
O	O	267	278	immunogenic	immunogenic	I-NP	JJ	O	39	NMOD	O
O	O	279	285	murine	murine	I-NP	JJ	O	39	NMOD	O
O	O	286	294	melanoma	melanoma	I-NP	NN	O	39	NMOD	O
O	O	295	297	D5	D5	I-NP	NN	O	33	PMOD	O
O	O	297	298	.	.	O	.	O	15	P	O

O	O	299	302	The	The	B-NP	DT	O	2	NMOD	O
O	O	303	311	efficacy	efficacy	I-NP	NN	O	8	SUB	O
O	O	312	314	of	of	B-PP	IN	O	2	NMOD	O
O	O	315	318	the	the	B-NP	DT	O	7	NMOD	O
O	O	319	328	activated	activate	I-NP	VBN	B-cell_type	7	NMOD	B-cell_type
O	O	329	331	LN	LN	I-NP	NN	I-cell_type	7	NMOD	I-cell_type
O	O	332	337	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	338	340	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	341	350	augmented	augment	I-VP	VBN	O	8	VC	O
O	O	351	355	when	when	B-ADVP	WRB	O	9	VMOD	O
O	O	356	359	the	the	B-NP	DT	O	13	NMOD	O
O	O	360	371	sensitizing	sensitize	I-NP	VBG	O	13	NMOD	O
O	O	372	377	tumor	tumor	I-NP	NN	O	14	SUB	O
O	O	378	380	is	be	B-VP	VBZ	O	10	SBAR	O
O	O	381	382	a	a	B-NP	DT	O	18	NMOD	O
O	O	383	394	genetically	genetically	I-NP	RB	B-cell_line	18	NMOD	B-cell_line
O	O	395	403	modified	modify	I-NP	VBN	I-cell_line	18	NMOD	I-cell_line
O	O	404	411	variant	variant	I-NP	NN	I-cell_line	14	PRD	I-cell_line
O	O	412	413	(	(	O	(	O	18	NMOD	O
O	O	413	423	designated	designate	B-NP	VBN	O	18	NMOD	O
O	O	424	428	D5G6	D5G6	I-NP	NN	B-cell_line	20	VMOD	B-cell_line
O	O	428	429	)	)	O	)	O	18	NMOD	O
O	O	430	434	that	that	B-NP	WDT	O	18	NMOD	O
O	O	435	443	secretes	secrete	B-VP	VBZ	O	23	SBAR	O
T3	B-Protein	444	455	granulocyte	granulocyte	B-NP	NN	B-protein	32	NMOD	B-protein
T3	I-Protein	455	456	/	/	I-NP	SYM	I-protein	32	P	I-protein
T3	I-Protein	456	466	macrophage	macrophage	I-NP	NN	I-protein	32	NMOD	I-protein
T3	I-Protein	466	467	-	-	B-NP	HYPH	I-protein	32	NMOD	I-protein
T3	I-Protein	467	473	colony	colony	I-NP	NN	I-protein	32	NMOD	I-protein
T3	I-Protein	473	474	-	-	O	HYPH	I-protein	32	NMOD	I-protein
T3	I-Protein	474	485	stimulating	stimulate	B-VP	VBG	I-protein	32	NMOD	I-protein
T3	I-Protein	486	492	factor	factor	B-NP	NN	I-protein	24	OBJ	I-protein
O	O	492	493	.	.	O	.	O	8	P	O

O	O	494	496	In	In	B-PP	IN	O	27	VMOD	O
O	O	497	505	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	506	508	to	to	B-PP	TO	O	2	NMOD	O
O	O	509	513	anti	anti	B-NP	AFX	O	14	NMOD	O
O	O	513	514	-	-	I-NP	HYPH	O	14	NMOD	O
T17	B-Entity	514	517	CD3	CD3	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	517	518	/	/	B-NP	SYM	O	9	P	O
T4	B-Protein	518	520	IL	IL	I-NP	NN	B-protein	9	NMOD	B-protein
T4	I-Protein	520	521	-	-	B-NP	HYPH	I-protein	14	NMOD	I-protein
T4	I-Protein	521	522	2	2	I-NP	CD	I-protein	9	NMOD	I-protein
O	O	522	523	-	-	I-NP	HYPH	O	14	NMOD	O
O	O	523	532	activated	activate	I-NP	VBN	B-cell_type	14	NMOD	B-cell_type
O	O	533	535	LN	LN	I-NP	NN	I-cell_type	14	NMOD	I-cell_type
O	O	536	541	cells	cell	I-NP	NNS	I-cell_type	3	PMOD	I-cell_type
O	O	541	542	,	,	O	,	O	27	P	O
O	O	543	551	adoptive	adoptive	B-NP	JJ	O	17	NMOD	O
O	O	552	560	transfer	transfer	I-NP	NN	O	27	SUB	O
O	O	561	563	of	of	B-PP	IN	O	17	NMOD	O
O	O	564	571	freshly	freshly	B-NP	RB	O	20	AMOD	O
O	O	572	580	isolated	isolate	I-NP	VBN	O	21	NMOD	O
O	O	581	586	tumor	tumor	I-NP	NN	O	18	PMOD	O
O	O	586	587	-	-	O	HYPH	O	17	P	O
O	O	587	595	draining	drain	B-VP	VBG	O	17	NMOD	O
O	O	596	598	LN	LN	B-NP	NN	B-cell_type	26	NMOD	B-cell_type
O	O	599	600	T	T	I-NP	NN	I-cell_type	26	NMOD	I-cell_type
O	O	601	606	cells	cell	I-NP	NNS	I-cell_type	23	OBJ	I-cell_type
O	O	607	610	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	611	613	no	no	B-NP	DT	O	30	NMOD	O
O	O	614	625	therapeutic	therapeutic	I-NP	JJ	O	30	NMOD	O
O	O	626	634	activity	activity	I-NP	NN	O	27	OBJ	O
O	O	634	635	.	.	O	.	O	27	P	O

O	O	636	638	To	To	B-VP	TO	O	2	VMOD	O
O	O	639	648	determine	determine	I-VP	VB	O	37	VMOD	O
O	O	649	656	whether	whether	B-SBAR	IN	O	2	VMOD	O
O	O	657	660	the	the	B-NP	DT	O	5	NMOD	O
O	O	661	672	acquisition	acquisition	I-NP	NN	O	13	SUB	O
O	O	673	675	of	of	B-PP	IN	O	5	NMOD	O
O	O	676	685	antitumor	antitumor	B-NP	JJ	O	8	NMOD	O
O	O	686	694	function	function	I-NP	NN	O	6	PMOD	O
O	O	695	701	during	during	B-PP	IN	O	5	NMOD	O
O	O	702	704	ex	ex	B-NP	FW	O	11	AMOD	O
O	O	705	709	vivo	vivo	I-NP	FW	O	12	NMOD	O
O	O	710	720	activation	activation	I-NP	NN	O	9	PMOD	O
O	O	721	723	is	be	B-VP	VBZ	O	3	SBAR	O
O	O	724	734	associated	associate	I-VP	VBN	O	13	VC	O
O	O	735	739	with	with	B-PP	IN	O	14	VMOD	O
O	O	740	753	modifications	modification	B-NP	NNS	O	15	PMOD	O
O	O	754	756	in	in	B-PP	IN	O	16	NMOD	O
O	O	757	763	signal	signal	B-NP	NN	O	20	NMOD	O
O	O	764	776	transduction	transduction	I-NP	NN	O	20	NMOD	O
O	O	777	785	capacity	capacity	I-NP	NN	O	17	PMOD	O
O	O	785	786	,	,	O	,	O	37	P	O
O	O	787	790	the	the	B-NP	DT	O	25	NMOD	O
O	O	791	798	protein	protein	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	799	807	tyrosine	tyrosine	I-NP	NN	I-protein	25	NMOD	I-protein
O	O	808	815	kinases	kinase	I-NP	NNS	I-protein	30	NMOD	I-protein
T5	B-Protein	816	822	p56lck	p56lck	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	823	826	and	and	I-NP	CC	O	28	NMOD	O
T6	B-Protein	827	833	p59fyn	p59fyn	I-NP	NN	B-protein	25	NMOD	B-protein
O	O	834	837	and	and	I-NP	CC	O	30	NMOD	O
O	O	838	846	proteins	protein	I-NP	NNS	O	37	SUB	O
O	O	847	849	of	of	B-PP	IN	O	30	NMOD	O
O	O	850	853	the	the	B-NP	DT	O	36	NMOD	O
O	O	854	856	NF	NF	I-NP	NN	B-protein	36	NMOD	B-protein
O	O	856	857	-	-	B-NP	HYPH	I-protein	36	NMOD	I-protein
O	O	857	863	kappaB	kappaB	I-NP	NN	I-protein	36	NMOD	I-protein
O	O	864	870	family	family	I-NP	NN	I-protein	31	PMOD	I-protein
O	O	871	875	were	be	B-VP	VBD	O	0	ROOT	O
O	O	876	884	analyzed	analyze	I-VP	VBN	O	37	VC	O
O	O	885	887	in	in	B-PP	IN	O	38	VMOD	O
O	O	888	893	tumor	tumor	B-NP	NN	B-cell_type	45	NMOD	B-cell_type
O	O	893	894	-	-	O	HYPH	I-cell_type	40	P	I-cell_type
O	O	894	902	draining	drain	B-VP	VBG	I-cell_type	45	NMOD	I-cell_type
O	O	903	905	LN	LN	B-NP	NN	I-cell_type	45	NMOD	I-cell_type
O	O	906	907	T	T	I-NP	NN	I-cell_type	45	NMOD	I-cell_type
O	O	908	913	cells	cell	I-NP	NNS	I-cell_type	39	PMOD	I-cell_type
O	O	913	914	.	.	O	.	O	37	P	O

O	O	915	918	The	The	B-NP	DT	O	2	NMOD	O
O	O	919	925	levels	level	I-NP	NNS	O	7	SUB	O
O	O	926	928	of	of	B-PP	IN	O	2	NMOD	O
T7	B-Protein	929	935	p56lck	p56lck	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	936	939	and	and	I-NP	CC	O	6	NMOD	O
T8	B-Protein	940	946	p59fyn	p59fyn	I-NP	NN	B-protein	3	PMOD	B-protein
O	O	947	951	were	be	B-VP	VBD	O	0	ROOT	O
O	O	952	957	lower	low	B-ADJP	JJR	O	7	PRD	O
O	O	958	960	in	in	B-PP	IN	O	8	AMOD	O
O	O	961	966	tumor	tumor	B-NP	NN	O	9	PMOD	O
O	O	966	967	-	-	O	HYPH	O	8	P	O
O	O	967	975	draining	drain	B-VP	VBG	O	8	AMOD	O
O	O	976	980	than	than	B-SBAR	IN	O	12	VMOD	O
O	O	981	983	in	in	B-PP	IN	O	26	VMOD	O
O	O	984	990	normal	normal	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	991	993	LN	LN	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	994	995	T	T	I-NP	NN	I-cell_type	18	NMOD	I-cell_type
O	O	996	1001	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	1002	1005	and	and	O	CC	O	14	PMOD	O
O	O	1006	1016	production	production	B-NP	NN	O	26	SUB	O
O	O	1017	1019	of	of	B-PP	IN	O	20	NMOD	O
T18	B-Entity	1020	1028	tyrosine	tyrosine	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	1028	1029	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
O	O	1029	1043	phosphorylated	phosphorylate	I-NP	VBN	I-protein	25	NMOD	I-protein
O	O	1044	1054	substrates	substrate	I-NP	NNS	I-protein	21	PMOD	I-protein
O	O	1055	1058	was	be	B-VP	VBD	O	13	SBAR	O
O	O	1059	1067	markedly	markedly	I-VP	RB	O	26	VMOD	O
O	O	1068	1077	depressed	depress	I-VP	VBN	O	26	VC	O
O	O	1078	1087	following	follow	B-PP	VBG	O	28	VMOD	O
O	O	1088	1092	anti	anti	B-NP	AFX	O	33	NMOD	O
O	O	1092	1093	-	-	I-NP	HYPH	O	33	NMOD	O
T19	B-Entity	1093	1096	CD3	CD3	I-NP	NN	B-protein	33	NMOD	B-protein
O	O	1097	1108	stimulation	stimulation	I-NP	NN	O	29	PMOD	O
O	O	1108	1109	.	.	O	.	O	7	P	O

O	O	1110	1115	After	After	B-PP	IN	O	24	VMOD	O
O	O	1116	1117	5	5	B-NP	CD	O	4	NMOD	O
O	O	1117	1118	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	1118	1121	day	day	I-NP	NN	O	24	SUB	O
O	O	1122	1126	anti	anti	O	AFX	O	24	VMOD	O
O	O	1126	1127	-	-	O	HYPH	O	24	P	O
T20	B-Entity	1127	1130	CD3	CD3	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	1130	1131	/	/	B-NP	SYM	O	12	NMOD	O
T9	B-Protein	1131	1133	IL	IL	I-NP	NN	B-protein	12	NMOD	B-protein
T9	I-Protein	1133	1134	-	-	O	HYPH	I-protein	12	NMOD	I-protein
T9	I-Protein	1134	1135	2	2	B-NP	CD	I-protein	12	NMOD	I-protein
O	O	1136	1146	activation	activation	I-NP	NN	O	24	SUB	O
O	O	1146	1147	,	,	O	,	O	24	P	O
O	O	1148	1154	levels	level	B-NP	NNS	O	24	SUB	O
O	O	1155	1157	of	of	B-PP	IN	O	14	NMOD	O
T10	B-Protein	1158	1164	p56lck	p56lck	B-NP	NN	B-protein	23	NMOD	B-protein
O	O	1165	1168	and	and	I-NP	CC	O	23	NMOD	O
T11	B-Protein	1169	1175	p59fyn	p59fyn	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	1176	1179	and	and	I-NP	CC	O	23	NMOD	O
O	O	1180	1187	protein	protein	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	1188	1196	tyrosine	tyrosine	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	1197	1203	kinase	kinase	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	1204	1212	activity	activity	I-NP	NN	O	15	PMOD	O
O	O	1213	1222	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	1222	1223	.	.	O	.	O	24	P	O

O	O	1224	1237	Interestingly	Interestingly	B-ADVP	RB	O	14	VMOD	O
O	O	1237	1238	,	,	O	,	O	14	P	O
O	O	1239	1242	the	the	B-NP	DT	O	4	NMOD	O
O	O	1243	1249	levels	level	I-NP	NNS	O	14	SUB	O
O	O	1250	1252	of	of	B-PP	IN	O	4	NMOD	O
T12	B-Protein	1253	1259	p56lck	p56lck	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1259	1260	,	,	O	,	O	13	P	O
T13	B-Protein	1261	1267	p59fyn	p59fyn	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1267	1268	,	,	O	,	O	13	P	O
O	O	1269	1272	and	and	O	CC	O	13	NMOD	O
O	O	1273	1281	tyrosine	tyrosine	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	1282	1288	kinase	kinase	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	1289	1297	activity	activity	I-NP	NN	O	5	PMOD	O
O	O	1298	1302	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1303	1309	higher	high	B-ADJP	JJR	O	14	PRD	O
O	O	1310	1312	in	in	B-PP	IN	O	14	VMOD	O
O	O	1313	1322	activated	activate	B-NP	VBN	B-cell_type	19	NMOD	B-cell_type
O	O	1323	1324	T	T	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	1325	1330	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	1331	1338	derived	derive	B-VP	VBN	O	19	NMOD	O
O	O	1339	1343	from	from	B-PP	IN	O	20	VMOD	O
O	O	1344	1346	LN	LN	B-NP	NN	O	21	PMOD	O
O	O	1347	1351	that	that	B-NP	WDT	O	22	NMOD	O
O	O	1352	1359	drained	drain	B-VP	VBD	O	23	SBAR	O
O	O	1360	1364	D5G6	D5G6	B-NP	NN	O	24	OBJ	O
O	O	1365	1369	than	than	B-SBAR	IN	O	14	VMOD	O
O	O	1370	1374	they	they	B-NP	PRP	O	28	SUB	O
O	O	1375	1379	were	be	B-VP	VBD	O	26	SBAR	O
O	O	1380	1382	in	in	B-PP	IN	O	28	VMOD	O
O	O	1383	1388	those	those	B-NP	DT	O	29	PMOD	O
O	O	1389	1393	from	from	B-PP	IN	O	30	NMOD	O
O	O	1394	1396	D5	D5	B-NP	NN	O	33	NMOD	O
O	O	1397	1403	tumors	tumor	I-NP	NNS	O	31	PMOD	O
O	O	1403	1404	.	.	O	.	O	14	P	O

O	O	1405	1407	In	In	B-PP	IN	O	14	VMOD	O
O	O	1408	1416	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1416	1417	,	,	O	,	O	14	P	O
O	O	1418	1421	the	the	B-NP	DT	O	6	NMOD	O
O	O	1422	1433	cytoplasmic	cytoplasmic	I-NP	JJ	O	6	NMOD	O
O	O	1434	1440	levels	level	I-NP	NNS	O	14	SUB	O
O	O	1441	1443	of	of	B-PP	IN	O	6	NMOD	O
T14	B-Protein	1444	1445	c	c	B-NP	NN	B-protein	10	NMOD	B-protein
T14	I-Protein	1445	1446	-	-	B-NP	HYPH	I-protein	10	NMOD	I-protein
T14	I-Protein	1446	1449	Rel	Rel	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	1450	1453	and	and	I-NP	CC	O	13	NMOD	O
T15	B-Protein	1454	1457	Rel	Rel	I-NP	NN	B-protein	13	NMOD	B-protein
T15	I-Protein	1458	1459	A	A	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	1460	1464	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1465	1471	normal	normal	B-ADJP	JJ	O	14	PRD	O
O	O	1472	1474	in	in	B-PP	IN	O	14	VMOD	O
O	O	1475	1482	freshly	freshly	B-NP	RB	O	18	AMOD	O
O	O	1483	1491	isolated	isolate	I-NP	VBN	O	19	NMOD	O
O	O	1492	1497	tumor	tumor	I-NP	NN	O	16	PMOD	O
O	O	1497	1498	-	-	O	HYPH	O	19	P	O
O	O	1498	1506	draining	drain	B-VP	VBG	O	19	NMOD	O
O	O	1507	1509	LN	LN	B-NP	NN	O	21	OBJ	O
O	O	1509	1510	,	,	O	,	O	14	P	O
O	O	1511	1513	as	as	B-SBAR	IN	O	14	VMOD	O
O	O	1514	1517	was	be	B-VP	VBD	O	24	DEP	O
O	O	1518	1525	nuclear	nuclear	B-NP	JJ	O	31	NMOD	O
T21	B-Entity	1526	1532	kappaB	kappaB	I-NP	NN	O	31	NMOD	O
T22	I-Entity	1533	1536	DNA	DNA	I-NP	NN	O	31	NMOD	O
O	O	1536	1537	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	1537	1544	binding	binding	I-NP	NN	O	31	NMOD	O
O	O	1545	1553	activity	activity	I-NP	NN	O	25	SUB	O
O	O	1554	1561	induced	induce	B-VP	VBN	O	31	NMOD	O
O	O	1562	1564	by	by	B-PP	IN	O	32	VMOD	O
O	O	1565	1569	anti	anti	B-NP	AFX	B-protein	37	NMOD	B-protein
O	O	1569	1570	-	-	I-NP	HYPH	I-protein	37	NMOD	I-protein
T23	B-Entity	1570	1573	CD3	CD3	I-NP	NN	I-protein	37	NMOD	I-protein
O	O	1574	1577	mAb	mAb	I-NP	NN	I-protein	41	NMOD	I-protein
O	O	1578	1580	or	or	O	CC	O	41	NMOD	O
O	O	1581	1588	phorbol	phorbol	B-NP	NN	O	41	NMOD	O
O	O	1589	1598	myristate	myristate	I-NP	NN	O	41	NMOD	O
O	O	1599	1606	acetate	acetate	I-NP	NN	O	33	PMOD	O
O	O	1606	1607	.	.	O	.	O	14	P	O

O	O	1608	1619	Stimulation	Stimulation	B-NP	NN	O	10	SUB	O
O	O	1620	1622	of	of	B-PP	IN	O	1	NMOD	O
O	O	1623	1632	activated	activate	B-NP	VBN	B-cell_type	5	NMOD	B-cell_type
O	O	1633	1635	LN	LN	I-NP	NN	I-cell_type	5	NMOD	I-cell_type
O	O	1636	1641	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	1642	1646	with	with	B-PP	IN	O	1	NMOD	O
O	O	1647	1649	D5	D5	B-NP	NN	B-cell_type	9	NMOD	B-cell_type
O	O	1650	1655	tumor	tumor	I-NP	NN	I-cell_type	9	NMOD	I-cell_type
O	O	1656	1661	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	1662	1669	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	1670	1673	the	the	B-NP	DT	O	13	NMOD	O
O	O	1674	1681	nuclear	nuclear	I-NP	JJ	O	13	NMOD	O
O	O	1682	1695	translocation	translocation	I-NP	NN	O	10	OBJ	O
O	O	1696	1698	of	of	B-PP	IN	O	13	NMOD	O
T24	B-Entity	1699	1701	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T24	I-Entity	1701	1702	-	-	B-NP	HYPH	I-protein	17	NMOD	I-protein
T24	I-Entity	1702	1708	kappaB	kappaB	I-NP	NN	I-protein	14	PMOD	I-protein
O	O	1708	1709	.	.	O	.	O	10	P	O

O	O	1710	1715	These	These	B-NP	DT	O	2	NMOD	O
O	O	1716	1724	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	1725	1733	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1734	1738	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1739	1742	the	the	B-NP	DT	O	6	NMOD	O
O	O	1743	1751	recovery	recovery	I-NP	NN	O	27	SUB	O
O	O	1752	1754	of	of	B-PP	IN	O	6	NMOD	O
O	O	1755	1763	proteins	protein	B-NP	NNS	O	7	PMOD	O
O	O	1764	1773	mediating	mediate	B-VP	VBG	O	8	NMOD	O
O	O	1774	1780	signal	signal	B-NP	NN	O	11	NMOD	O
O	O	1781	1793	transduction	transduction	I-NP	NN	O	9	OBJ	O
O	O	1794	1801	through	through	B-PP	IN	O	9	VMOD	O
O	O	1802	1805	the	the	B-NP	DT	O	16	NMOD	O
T25	B-Entity	1806	1807	T	T	I-NP	NN	B-protein	16	NMOD	B-protein
T25	I-Entity	1808	1812	cell	cell	I-NP	NN	I-protein	16	NMOD	I-protein
T25	I-Entity	1813	1821	receptor	receptor	I-NP	NN	I-protein	19	NMOD	I-protein
T25	I-Entity	1821	1822	/	/	B-NP	SYM	O	19	NMOD	O
T25	I-Entity	1822	1825	CD3	CD3	I-NP	NN	B-protein	19	NMOD	B-protein
T25	I-Entity	1826	1833	complex	complex	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	1834	1836	in	in	B-PP	IN	O	19	NMOD	O
O	O	1837	1839	LN	LN	B-NP	NN	B-cell_type	23	NMOD	B-cell_type
O	O	1840	1841	T	T	I-NP	NN	I-cell_type	23	NMOD	I-cell_type
O	O	1842	1847	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	1848	1857	activated	activate	B-VP	VBD	O	23	NMOD	O
O	O	1858	1860	ex	ex	B-ADVP	FW	O	24	VMOD	O
O	O	1861	1865	vivo	vivo	I-ADVP	FW	O	25	AMOD	O
O	O	1866	1869	was	be	B-VP	VBD	O	4	SBAR	O
O	O	1870	1880	associated	associate	I-VP	VBN	O	27	VC	O
O	O	1881	1885	with	with	B-PP	IN	O	28	VMOD	O
O	O	1886	1889	the	the	B-NP	DT	O	31	NMOD	O
O	O	1890	1901	acquisition	acquisition	I-NP	NN	O	29	PMOD	O
O	O	1902	1904	of	of	B-PP	IN	O	31	NMOD	O
O	O	1905	1914	antitumor	antitumor	B-NP	JJ	O	34	NMOD	O
O	O	1915	1923	function	function	I-NP	NN	O	32	PMOD	O
O	O	1923	1924	.	.	O	.	O	3	P	O
